Pfizer Stomach Cancer Pill Wins EU 'Orphan' Status

Pfizer Inc's experimental drug for a deadly form of stomach cancer has been recommended for so-called orphan drug status in the European Union, the European Medicines Agency said.

Reuters (http://www.reuters.com/newsArticle.jhtml?type=healthNews&storyID=7648094&src=rss/healthNews)